We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$1.56B
AUM Growth
+$124M
Cap. Flow
+$34.8M
Cap. Flow %
2.22%
Top 10 Hldgs %
38.06%
Holding
266
New
17
Increased
104
Reduced
88
Closed
14

Top Buys

Rank Stock Value
1
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$18.3M
2
SPEM icon
State Street SPDR Portfolio Emerging Markets ETF
SPEM
+$14.9M
3
XLB icon
State Street Materials Select Sector SPDR ETF
XLB
+$10.1M
4
CBOE icon
Cboe Global Markets
CBOE
+$8.97M
5
FPE icon
First Trust Preferred Securities and Income ETF
FPE
+$8.29M

Top Sells

Rank Stock Value
1
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$13M
2
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$12M
3
SPSM icon
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
+$9.58M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$9.24M
5
PKG icon
Packaging Corp of America
PKG
+$6.86M

Sector Composition

Rank Sector Weight
1 Technology 11.12%
2 Healthcare 7.47%
3 Industrials 5.2%
4 Financials 5.17%
5 Communication Services 3.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRV icon
226
Travelers Companies
TRV
$78.1B
$227K 0.01%
2,097
– –
BP icon
227
BP
BP
$116B
$220K 0.01%
12,622
-74
-0.6% -$1.6K
COST icon
228
Costco
COST
$422B
$219K 0.01%
+618
New +$208K
VOO icon
229
Vanguard S&P 500 ETF
VOO
$993B
$216K 0.01%
+702
New +$214K
ARKG icon
230
ARK Genomic Revolution ETF
ARKG
$1.6B
$214K 0.01%
+3,365
New +$197K
PSA icon
231
Public Storage
PSA
$60.5B
$214K 0.01%
961
-201
-17% -$41.1K
EZU icon
232
iShare MSCI Eurozone ETF
EZU
$9.73B
$210K 0.01%
5,533
– –
LHX icon
233
L3Harris
LHX
$51.6B
$206K 0.01%
1,210
– –
MRNS
234
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$145K 0.01%
11,250
+7,125
+173% +$61.5K
RF icon
235
Regions Financial
RF
$26.4B
$133K 0.01%
11,502
– –
IRWD icon
236
Ironwood Pharmaceuticals
IRWD
$696M
$126K 0.01%
14,007
+2,622
+23% +$26.1K
CALA
237
DELISTED
Calithera Biosciences, Inc
CALA
$122K 0.01%
1,765
+720
+69% +$62.8K
LJPC
238
DELISTED
La Jolla Pharmaceutical Company
LJPC
$102K 0.01%
25,270
+1,770
+8% +$7.33K
HBAN icon
239
Huntington Bancshares
HBAN
$34.4B
$92K 0.01%
10,076
-2,297
-19% -$21.4K
AGRX
240
DELISTED
Agile Therapeutics
AGRX
$89K 0.01%
15
+4
+36% +$22.9K
ADMA icon
241
ADMA Biologics
ADMA
$1.96B
$80K 0.01%
+33,500
New +$91.9K
ASX icon
242
ASE Group
ASX
$77.3B
$57K ﹤0.01%
13,925
+2,751
+25% +$12.3K
BCRX icon
243
BioCryst Pharmaceuticals
BCRX
$2.28B
$52K ﹤0.01%
+15,000
New +$64.3K
RBBN icon
244
Ribbon Communications
RBBN
$377M
$39K ﹤0.01%
10,030
– –
AWRE icon
245
Aware
AWRE
$26M
$27K ﹤0.01%
+10,117
New +$29.5K
ALNA
246
DELISTED
Allena Pharmaceuticals
ALNA
$17K ﹤0.01%
+11,289
New +$15.9K
RGLS
247
DELISTED
Regulus Therapeutics
RGLS
$12K ﹤0.01%
2,400
+450
+23% +$2.96K
AAC
248
DELISTED
AAC Holdings
AAC
$1K ﹤0.01%
45,454
-15,000
-25% -$330
ALC icon
249
Alcon
ALC
$33.6B
– –
-11,258
Closed -$645K
F icon
250
Ford
F
$58.5B
– –
-10,497
Closed -$64K
7 8 9
10
11

Similar funds

DWM
Dakota Wealth Management Palm Beach Gardens, Florida $4.62B AUM 33.09% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
AG
AlTi Global New York $4.6B AUM 22.54% 1-Year Est. Return
SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Grimes & Company's Q3 2020 Portfolio in Review

As of Q3 2020, Grimes & Company held 266 positions worth $1.56B, up 8.6% from $1.44B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Grimes & Company's Q3 2020 filing shows 17 new, 104 increased, 88 reduced and 14 closed positions. Its largest new stake was State Street Materials Select Sector SPDR ETF: 323,702 shares worth $10.3M. The largest sale was iShares Core S&P Small-Cap ETF, an estimated $13M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Industrials.

  • Grimes & Company's largest Q3 2020 buy was State Street Materials Select Sector SPDR ETF: 323,702 shares worth $10.3M.
  • Grimes & Company added most to iShares Core MSCI Emerging Markets ETF in Q3 2020, an estimated $18.3M increase.
  • Grimes & Company's biggest Q3 2020 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $13M.
  • Grimes & Company fully exited State Street Energy Select Sector SPDR ETF in Q3 2020, selling an estimated $9.24M.
  • Grimes & Company's ten largest holdings make up 38% of its $1.56B portfolio in Q3 2020.
  • Grimes & Company opened 17 new positions and closed 14 in Q3 2020.
  • Grimes & Company's portfolio value rose 8.6% quarter-over-quarter to $1.56B.

Based on Grimes & Company's 13F filing for Q3 2020, filed 12 Nov 2020.